Cancer Genetics, Inc. New Clinical Trial Backlog Exceeds $13 Million

[GlobeNewswire] – RUTHERFORD, N.J. — Cancer Genetics, Inc. (CGI or the Company), an emerging leader in DNA-based diagnostics, initiated two additional multi-year clinical trial contracts with biopharmaceutical … more

View todays social media effects on CGIX

View the latest stocks trending across Twitter. Click to view dashboard

See who Cancer is hiring next, click here to view